Curriculum Vitae Ali Yaghobi Joybari · 2020. 6. 16. · 4. Behzadi, Behnaz, Evaluation of treatment outcomes of induction chemotherapy and then Neoadjuvant chemoradiotherapy and

TCURRICULUM VITAE

Ali Yaghobi Joybari Radiation Oncologist

Tehran-IRAN Assistant Professor Of Shahid Beheshti University Of Medical Sciences

Curriculum Vitae Ali Yaghobi Joybari

Curriculum Vitae

Personal Information

First Name:

Surname:

Specialty:

Academic Degree:

Affiliation:

Nationality:

Year of Birth:

Place of Birth:

Marital Status:

Personal Email :

Academic Email :

Website :

Phone:

Work Office:


Educational Background

1996; Admission to the Faculty of Medicine, Shahid Beheshti University of

Medical Sciences

2003: Received a doctorate in General Medicine

2006: Entry to the specialty course

2009: Obtaining a specialized certificate in the field of Radiotherapy-Oncology

from Shahid Beheshti University of Medical Sciences

2010: Obtaining a specialized board in the field of Radiotherapy - Oncology

2010: Member of the faculty of the Department of Radiotherapy-Oncology,

Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital

Skills

o Complete computer proficiency

o Familiarity with operating systems: Windows (XP, Vista, Seven) and Macintosh

o Familiarity with software package (Word, PowerPoint, Excel) office

o Ability to use the Internet and access to scientific articles of the day in full

o Ability to design a website

o Familiarity with information processing in SPSS software

o Persian and English typing

Foreign Languages

o Full command of English

o Learning French

o Arabic

Familiarity with the basics

o Curriculum writing

o Writing articles in Persian

o Writing articles in English

o Tariff writing


Full mastery of clinical medical examinations

o Clinical evaluation by the OSCE test

o Principles of designing four-choice questions

Membership

1. Member of the Council of Representation of Medical Students of Mehr 75

Shahid Beheshti University of Medical Sciences 76-78

2. Member of the Central Council of the Student Council (Guild) of Shahid

Beheshti University of Medical Sciences 77-80

3. Head of the Electoral Committee of the Student (Guild) Council of Shahid

Beheshti University of Medical Sciences77-80

4. Active member of the Iranian Radiotherapy-Oncology Association since 2006

5. Active member of the Iranian Cancer Society since 2007

6. Member of the faculty of the Department of Radiotherapy-Oncology, Shahid

Beheshti University of Medical Sciences since 2008

7. Official member of the European Medical Association ESMO (membership

number 73654)

8. Member of the Editorial Board of the Scientific Scientific Journal of the Iranian

Pathological Association (in Persian)

9. Secretary of Oncology Scientific Journal of Iranian Pathology Association (in

Persian)

10. Scientific Secretary of the Analytical Scientific News Magazine of the Iranian

Cancer Society (in Persian and English)

11. Member of the judging committee of the Iranian Journal of Pathology

12. Secretary of the Education Committee of the Iranian Cancer Society

13. Interconnection of Oncology Radiotherapy Department of Shahid Beheshti

University of Medical Sciences with the Office of Continuing Education

14. Member of the Question Design Committee of the Oncology Radiation

Assistance Promotion Test at Shahid Beheshti University of Medical Sciences


15. The main member of the organizer of the OSCE in-university exams in the field

of oncology radiotherapy in 2010, Shahid Beheshti University of Medical

Sciences

16. Collaborating member in compiling the audit booklet of the specialized field of

oncology radiotherapy developed by the Scientific Association of Oncology

Radiotherapy

17. Collaborating member in compiling an audit booklet on the field of oncology

developed by the Iranian Scientific Association of Cancer

18. Member of the Scientific-Specialized Committee for Error Analysis of Shahid

Beheshti University of Medical Sciences on behalf of the Oncology Radiotherapy

Department

19. Member of the tariff writing group of the Iranian Oncology Radiotherapy

Association in compiling radiotherapy codes for coding Iran's oncology

radiotherapy services

20. Connection of Oncology Radiotherapy Department of Shahid Beheshti

University of Medical Sciences with the Research Vice Chancellor of the Faculty

of Medicine

21. Member of the Tariff Committee of the Iranian Oncology Radiotherapy

Association

22. Member of the Scientific Committee of the Iranian Oncology Radiotherapy

Association

23. Member of the Curriculum Committee of the Radiotherapy-Oncology

Department of the Iranian Oncology Radiotherapy Association

24. In charge of the examination committee of the Oncology Radiotherapy

Department of Shahid Beheshti University of Medical Sciences since 2017

25. Member of the Strategic Committee of the Radiotherapy-Oncology Department

of Shahid Beheshti University of Medical Sciences since 2017

26. Member of the Recruitment Committee of the Radiotherapy-Oncology

Department of Shahid Beheshti University of Medical Sciences since 2017


27. Member of the Guideline Committee of Oncology in Ministry of Health since

2017

28. Member of the Guideline Committee of Uro oncology in SBMU kidney research

center since 2016

Thesis (THESIS):

I. To receive a General Doctorate

1. Bone Densitometry in Tehran population

II. - To receive a Specialized Doctorate

1. Comparison of 5FU-based chemoradiation with and without Eloxatin on

Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer

The article extracted from this dissertation, in addition to being published in the

Iranian Journal of Pathology, won the top rank in the 5th Annual Congress of the

Iranian Cancer Society.

III. Thesis Supervisor

1. Zandian, Roya, Comparison of taxol/carboplatin vs. cisplatin/5-fluorouracil

regimens in definitive chemoradiotherapy for clinical complete response in

patients with esophageal cancer

2. Zamani, Jalal, Evaluation of DFS Between weekly & 3-weeks paclitaxel

chemotherapy in adjuvant breast cancer

3. Jozian, Fariba, The value of DW-MRI in predicting pathologic complete

response (pCR) after neoadjuvant chemoradiation in patient with rectal cancer

who referred to Imam Hossein hospital during July 2018 to July 2019

4. Behzadi, Behnaz, Evaluation of treatment outcomes of induction chemotherapy

and then Neoadjuvant chemoradiotherapy and surgery in locally advanced

rectal cancer

5. Arjmand, Yasaman, Evaluation of Estrogen, Progesterone & HER2 receptor in

Iranian population of Breast Cancer


IV. Thesis Advisor & Consultant

1. Ghiasi, Hoseinali, The impact of capecitabine on fingerprints in patients

treated with this drug

2. Rajabzadeh, Mania, A comparison survey on the combination Aprepitant -

dexamethasone - Ondansetron, vs. Placebo-dexamethasone - Ondansetron,

for prevention of Moderate Emetogenic Chemotherapy Regimens-Induced

Nausea and Vomiting,

3. Babaei, Siamak, HPV incidence in patients with rectal adenocarcinoma and

its correlation with Disease Free Survival, Mutant KRAS and BRAF gene

expression profiles in Iranian colorectal cancer patients

4. Mansouri, Hamdollah, the predictive value of cardiac biochemical markers

including high sensitive cardiac troponin-I (HSCT-I), NT-Pro-BNP and two

dimensional echocardiography in early detection of acute and sub acute

cardiac toxicity in patients who are treated by anthracycline drug

5. Khoshnoudi , Hojjat, Mutant KRAS and BRAF gene expression profiles in

Iranian colorectal cancer patients

PUBLICATION

I. Articles published in scientific journals: A-Written in English:

1.Yaghobi, Ali , Azadeh, Payam, Moghadam , Shiva, Shafaghi, Behrouz,

Primary Stromal sarcoma of the breast with nodal recurrence, Iranian Journal

of Pathology, Iranian Journal of Pathology (2010)5 (1), 43- 46.

2.Yaghobi, Ali , Azadeh, Payam, Sheibani , Kh.M, Foudazi , M., Shafaghi, B. ,

Davaei, M., Comparison of 5FU-based chemoradiation with and without

Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of

Rectal cancer, Iranian Journal of Pathology (2011) 6(3):110-116.

3. Azadeh , Payam, Yaghobi, Ali, Amini, Afshin, Farasatinasab, Maryam

Paclitaxel-Induced Fingerprints Loss, Annals of Pharmacotherapy, 2014, vol48

(9) 1249-1250.


4. Azadeh, Payam, Hassanzadeh Rad, Babak, Yaghobi, Ali , Orbital Metastasis

From Breast Cancer Without Significant Changes In CT Scan And MRI ,

Iranian Journal Of Radiology , 2016 , 13(2):e20004.

5. Yaghobi, Ali, Azadeh, Payam, Von Hippel-Lindau Disease with Multi-Organ

Involvement: A Case Report and 8-Year Clinical Course with Follow-Up , Am J

Case Rep, 2017, 18: 1220-1224.

6. Yaghobi, Ali, Sarbaz, Samaneh, Azadeh, Payam, Mirafsharieh, S.Abbas ,

Rahbari , Ali, Farasatinasab, Maryam, Mokhtari, Majid, Oxaliplatin-Induced

Renal Tubular Vacuolization, Annals Of Pharmacotherapy, 2014,vol48(6) 796-

800.

7. Azadeh, Payam, Yaghobi, Ali, Sarbaz, Samaneh, Ghiasi, Hosein Ali,

Farasatinasab, Maryam, Solitary Psoas Muscle Metastasis Of Gastroesophageal

Junction, Adenocarcinoma , Iranian Journal of Pathology, 2015

8. Yaghobi, Ali, Azadeh, Payam, Nemati Honar, Behzad, Cutaneous

Verrucous Carcinoma superimposed on Chronically Inflamed Ileostomy Site

Skin, a case report, , Iranian Journal of Pathology, 2018, 13(2): 209-217.

9. Azadeh, Payam, Rakhashani , Nasser, Yaghobi, Ali, Gorji Bayani, Pegah,

Sarbaz, Samaneh, Farasatinasab , Maryam, Jaw Pain as a First Presentation in

the Diagnosis of Breast Cancer , Iranian Journal of Pathology, 2016; 11(5):

439-442.

10. Azadeh, Payam , Khavidaki , Simin Dashti, Yaghobi, Ali , Sarbaz ,

Samaneh, Jafari , Atefeh, Yaseri, Mehdi, Amini, Afshin, Farasatinasab,

Maryam, Fingerprint changes among cancer patients treated with paclitaxel , J

Cancer Res Clin Oncol , published online 2016

11. Yaghobi, Ali, Azadeh, Payam , Babaei, Siamak, Hosseini Kamal , Farnaz,

Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and

Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer

pathology and oncology research, 2019, 25(4): 1599-1605


12. Yaghobi, Ali, Azadeh, Payam. Ghiasi , Hosein A., Amouzegar, Atefeh , Yaseri , Mehdi,

Amini, Afshin , Farasatinasab3, Maryam, Mokhtari, Majid, Capecitabine induced

fingerprint changes, journal of clinical pharmacy and therapeutics , 2019,

44(5):780-787.

13. Yousefi Moteghaed, Niloofar , Yaghobi, Ali , Mostaar, Ahmad, Pseudo-CT

Generation for External Radiotherapy Planning from Magnetic Resonance

Imaging Data on Brain Regions , , Iranian Journal of Radiology, 2019,

16(3):e82804

14. Mostaar, Ahmad, Yaghobi, Ali, Medical Image Fusion Using BEMD and an

Efficient Fusion Schema, Journal of Biomedical Physics and Engineering , 2018

15. Rezapour, Jafar, Paydar, Reza, Mostaar, Ahmad, Yaghobi, Ali, Comparison

of breast absorbed dose in conventional and digital mamography machines in

the actual condition used in Tabriz , Research in Medicine 2018, 42(1): 40-45

16. Haddad, Peiman , Zali, Alireza, Tabatabaeefar, Morteza, Nikoofar, Alireza

, Hadizadeh Kharazi, Homayoun, Ghadyani, Mojtaba Fadavi, , Pedram ,

Vossough, Parvaneh, Mousavizadeh, Mirahmad, Mehdizadeh , Mahshid,

Motlagh, Ali, Amoozegar Hashemi, Farnaz, Ameri, Ahmad , Yaghobi, Ali,

Turning Interdisciplinary Brain Tumor Science into Survival; Report from the

Neuro-Oncology Scientific Club Opening Session, NOSC 2012 -19 January-

Tehran, IR Iran Report and Opinion, 2012;4:(2)

B-Written in Persian:

1. Yaghobi, Ali, Herceptin treatment in gastro esophageal adenocarcinoma,

Iranian Journal of Pathology, November 30, 2009 (consecutive 40)

2. Yaghobi, Ali, CDX2, CK7, CK20, CDX2 Useful markers for distinguishing

colorectal metastatic carcinoma with ovarian involvement from primary

ovarian adenocarcinoma , Iranian Journal of Pathology, Azar and D89

(consecutive 41)

3. Yaghobi, Ali, Pathological evaluation of TME rectal cancer sample, Iranian

Journal of Pathology, April and May 1990 (consecutive 43)

javascript:%20void(0)javascript:%20void(0)http://rsf.research.ac.ir/Index.php?itemId=3098


4. Yaghobi, Ali, Treatment and prophylaxis of VTE in cancer patients:

Commentary agreed by the main guidelines in the eighth issue of the

Scientific-News Magazine of the Iranian Cancer Society

5. Yaghobi, Ali, Prevention, diagnosis and treatment of VTE in cancer patients

in the book How to deal with oncology emergencies of the Iranian Cancer

Society

6. Yaghobi, Ali, New biological and diagnostic factors predicting the results of

treatment in early stage breast cancer, Iranian Journal of Pathology, June

and July 1990 (consecutive 44)

7. Yaghobi, Ali, Targeted value-added therapy in oncology, Iranian Journal of

Pathology, August and September 1990 (consecutive 45)

8. Yaghobi, Ali, IHC's position in the diagnosis of metastatic carcinoma of

unknown origin (CUP), Iranian Journal of Pathology, Mehr and Aban 90

(consecutive 46)

9. Yaghobi, Ali, Gastrointestinal Stromal Tumors (GIST), Iranian Journal of

Pathological Association, Bahman and Esfand 90 (consecutive 48)

10. Yaghobi, Ali, Diagnosis of pancreatic tumors by (EUS), Iranian Journal of

Pathology, April and May 1991 (consecutive 49)

11. Yaghobi, Ali, Molecular mechanism of resistance to cytotoxic resistance,

Iranian Journal of Pathology, Esfand 92 (consecutive 56)

12. Yaghobi, Ali, Hepatocellular carcinoma, Journal of the Iranian Society of

Pathology, Esfand 92 91 (consecutive 59.60)

13. Yaghobi, Ali, Treatment and prophylaxis of venous thromboembolism in

cancer patients, Iranian Journal of Pathology, July 1993 (consecutive, 6162)

14. Yaghobi, Ali, Agreed guidelines for the treatment of neuroendocrine tumors

with hepatic metastasis, Iranian Journal of Pathology, August and

September 1993 (consecutive 63)

15. Yaghobi, Ali, Non-functional pancreatic neuroendocrine tumors with good

differentiation, Iranian Journal of Pathology Association, Azar and D 93

(consecutive 65)

16. Yaghobi, Ali, Therapeutic Strategies and Effective Mechanisms to Targeted

Treatments in Small Non-Cellular Cancers, Iranian Journal of Pathology, 94

(consecutive 71)


17. Yaghobi, Ali, Should Dose Taxoter be an optional option in patients with

metastatic prostate cancer, Iranian Journal of Pathology, Bahman and

Esfand 94 (consecutive 72)

18. Yaghobi, Ali, A Review of Glioblastoma Multiform Treatment, Journal of

Iranian Pathology Association, June and July 2016 (consecutive 74)

19. Yaghobi, Ali, Instructions and management of patients with metastatic

colorectal cancer, Iranian Journal of Pathology, Bahman and Esfand 2016

(consecutive 78)

20. Yaghobi, Ali, treatment & diagnostic guideline in epithelial ovarian cancer,

Iranian Journal of Pathology, khordad & Tir 2016 , (consecutive 80)

21. Yaghobi, Ali, change of treatment protocol in metastatic melanoma, Iranian

Journal of Pathology, farvardin & ordibehesht 2018, (consecutive 85)

22. Yaghobi, Ali, metastatic breast cancer HR positive ,HER2 negative, Iranian

Journal of Pathology, Bahman & Esfand 2019, (consecutive 85)

23. Yaghobi, Ali, Immuno oncology fourth potent pillar in treatment of

oncology, Iranian Journal of Pathology, khordad & Tir 2019, (consecutive

85)

24. Yaghobi, Ali, treatment strategy in advanced breast cancer, Iranian Journal

of Pathology, Mehr & Aban 2019, (consecutive 85)

25. Yaghobi, Ali, integrity biomarkers & target therapy in management of

metastatic colorectal cancer, Iranian Journal of Pathology, Bahman &

Esfand 2020, (consecutive 85)

26. Yaghobi, Ali, what is ideal treatment in cancer of gastroesophageal junction

,farvardin & ordibehesht 2020 (consecutive 97)

27. Yaghobi, Ali, do you think what is ideal treatment for Gastroesophageal

junction carcinoma ? (consecutive 98)


II. books 1. Yaghobi, Ali, Azadeh, Payam, Chemotherapy book, Clinical Guide For

Patients & Families Volume 1, , Ali, Arjmand Publications, 2013

2. Yaghobi, Ali, Azadeh, Payam, Chemotherapy book, Clinical Guide For

Patients & Families Volume 1, Arjmand Publications, 2015, Second Edition

3. Yaghobi, Ali, Azadeh, Payam Chemotherapy book, Clinical Guide For

Patients & Families Volume 1, , Ali, Arjmand Publications, 2016, Third

Edition

4. Yaghobi, Ali, Azadeh, Payam Breast Cancer Book, Clinical Guide For

Patients & Families Volume 2, Arjmand Publications, 2013

5. Yaghobi, Ali, Azadeh, Payam Radiotherapy book, Clinical Guide For


6. Yaghobi, Ali, Azadeh, Payam Radiotherapy book, Clinical Guide For

Patients & Families Volume 3, Arjmand Publications, 2015, Second Edition

7. Yaghobi, Ali, Azadeh, Payam, Prostate Cancer Book, Clinical Guide For

Patients & Families Volume 4, , , Arjmand Publications, 2013

8. Yaghobi, Ali, Azadeh, Payam, Colorectal Cancer Book, Clinical Guide For

Patients & Families Volume 5, Colon Cancer , Ali Yaghobi Joybari ,Payam

Azadeh, Arjmand Publications, 2013

9. Yaghobi, Ali, Azadeh, Payam, Cancer Pharmacotherapy book, the first

volume , Chemotherapy Agents, Clinical Guide For Patients & Families

Volume 6, , Ali Yaghobi Joybari , Maryam Farasati nasab , Payam Azadeh,

Arjmand Publications, 2013

10. Yaghobi, Ali, Azadeh, Payam, Farasati nasab, Maryam, Cancer

Pharmacotherapy book, Second Volume, Targeted Therapy for Cancer,

Clinical Guide For Patients & Families Volume 7, Payam Azadeh, Arjmand

Publications, 2013

11. Yaghobi, Ali, Azadeh, Payam, Farasati nasab, Maryam Cancer

Pharmacotherapy book, third Volume, Hormone Therapy for Cancer,

Clinical Guide For Patients & Families Volume 8, Arjmand Publications,

2013

12. Yaghobi, Ali, Azadeh, Payam, Pancreatic Cancer Book ,Clinical Guide For



13. Yaghobi, Ali, Azadeh, Payam Esophageal Cancer Book ,Clinical Guide For


14. Yaghobi, Ali, Azadeh, Payam Coping with Cancer book ,Clinical Guide For


15. Yaghobi, Ali, Azadeh, Payam, Farasati nasab, Maryam, Marital

Relationships in Cancer Patients Clinical Guide For Patients & Families

Volume 12, Arjmand Publications, 2014

16. Yaghobi, Ali, Azadeh, Payam Gastric Cancer Book, Clinical Guide For


17. Yaghobi, Ali, Azadeh, Payam The Clinical Application of Blood Book,


2015

18. Yaghobi, Ali, Tizdast, Neda, Azadeh, Payam, Nutrition & Cancer Book ,


2014

19. Yaghobi, Ali, Tizdast, Neda, Azadeh, Payam, Nutrition & Cancer Book ,


Second Edition, 2017

20. Yaghobi, Ali, Azadeh, Payam, Nemati Honar, Behzad, Pain & Cancer Book

,Clinical Guide For Patients & Families Volume 16, Arjmand Publications,

2014

21. Taghizadeh, Ali, Yaghobi, Ali…[and etal], Principle Of Chemotherapy In

Special Clinical Situation Book, , Arjmand Publications, 2014

22. Yaghobi, Ali…[and etal], Thromboembolism & Cancer Book, , Arjmand

Publications, 2014


III. Slide

1. An overview of oncology radiotherapy reference books, including Perez's

Oncology Radiotherapy Book (2008) and DeVita's Clinical Oncology Book

(2008), which includes (more than 20,000) 20,000


9. Gene Testing Predicts Response to Erbitux in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008

10. Serum Tumor Markers in Breast Cancer: Are They of Clinical Value? in 4th Annual Congress of Iranian Cancer Association , Iran-Tehran oct.22-24 2008

11. Afinitor Earns FDA Approval for Advanced Kidney Cancer in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009

12. What's New in Chemotherapy Research? in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009

13. Metastatic Renal Cell Carcinoma in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009

14. Second-Line Treatment of Glioblastoma in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009

15. Glivec (imatinib) now approved in the UK for post surgery treatment of patients with KIT(CD117)-positive GIST, who are at significant risk of the cancer

returning after surgery in 3th Annual Congress of clinical oncology, Iran-

Tehran Feb.3-4 2010

16. Trastuzumab in HER2-positive advanced esophagogastric adenocarcinoma in 3th Annual Congress of clinical oncology, Iran-Tehran Feb.3-4 2010

17. Avastin delays progression of advanced ovarian cancer in 6th Annual Congress of Iranian Cancer Association, Iran-Tehran Nov. 17-19 2010

18. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic masses in 6th Annual Congress of

Iranian Cancer Association, Iran-Tehran Nov. 17-19 2010

19. SATURN trial in 6th Annual Congress of Iranian Cancer Association, Iran-Tehran Nov. 17-19 2010

20. New treatment options in the management of glioblastoma multiform :a focus of bevacizumab in Annual Congress of clinical oncology, Iran-Tehran 2011

21. CK7, CK20, CDX2 and MUC2 immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary

ovarian mucinous adenocarcinoma in Annual Congress of clinical oncology,

Iran-Tehran 2011


22. Tarceva outperforms chemotherapy for initial treatment of lung cancer with an EGFR mutation in 7th Annual Congress of Iranian Cancer Association,

Iran-Tehran Oct. 19 – 21 , 2011 , Iran-Tehran

23. Three years of adjuvant Imatinib may be the new standard of care for high risk patients with GIST in 7th Annual Congress of Iranian Cancer Association,

Iran-Tehran Oct. 19 – 21 , 2011 , Iran-Tehran

24. Advisory committee recommends Everolimus for approval to treat advanced NET of pancreatic origin in 7th Annual Congress of Iranian Cancer

Association, Iran-Tehran Oct. 19 – 21 , 2011 , Iran-Tehran

25. FOLFIRINOX versus Gemcitabine for metastatic pancreatic cancer in 7th Annual Congress of Iranian Cancer Association, Iran-Tehran Oct. 19 – 21 , 2011

, Iran-Tehran

26. FDA approves Abiraterone for metastatic pancreatic cancer in 7th Annual Congress of Iranian Cancer Association, Iran-Tehran Oct. 19 – 21 , 2011 , Iran-

Tehran

27. CAR T cell immunotherapy for human cancer in 1st National congress on inflammation ,Immunology and inflammatory disorders , 26 February 2019,

Tehran

28. Cancer Treatment with Immune Checkpoint Inhibitors in 1st National congress on inflammation ,Immunology and inflammatory disorders , 26 February 2019,

Tehran

II. Articles presented at the scientific congresses in the form of lectures (LECTURE):

1. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials in 4th Annual Congress of Iranian

Cancer Association, Iran-Tehran oct.22-24 2008

2. Can Antibodies Help Cure Cancer? in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009

3. Comparison of 5FU-base chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer

in 5th

Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22

2009


Scientific Congresses :

I. Lecture at Scientific Congresses

1. Lecture at the Conference on Treatment of Non-Melanoma Skin Tumors of the Iranian Association of Surgeons entitled: The role of radiotherapy in the

treatment of non-melanoma skin cancers, / 10/88, Tehran

2. Lecture at the two-day seminar on the new Rectum Cancer of Shahid Beheshti University of Medical Sciences, entitled: Radiotherapy and modern methods in

the treatment of rectal cancer, 5-4 / 12/89, Tehran

4. Lecture at the 35th Annual Congress of the Iranian Association of Surgeons Conference on Oncology entitled: update on metastatic breast cancer, 20-19 /

2/90, Tehran

5. Speech at the conference on how to deal with oncology emergencies of the Iranian Cancer Association ,entitled: Prevention, diagnosis and treatment of

VTE in cancer patients, 3/5/90, Tehran

6. Lecture at the conference on how to deal with bladder tumors of the Iranian Urological Association with the title: The position of radiotherapy in the

treatment of bladder cancers, 7/7/90, Tehran

7. Lecture at the Esophageal Cancer Conference of Shahid Beheshti University of Medical Sciences entitled: The position of Adjuvant and Neoadjuvant in the

treatment of Esophageal Cancer, 7/14/90, Tehran

8. Lecture at the Conference of Iranian Association of Surgeons entitled: Dealing with Cervical Masses, 2/91, Tehran

9. Lecture at the Tehran Congress of Clinical Oncology entitled: Dealing with Oligodendroglioma Tumors, 9/91, Tehran

10. Lecture at the Isfahan Congress of Clinical Oncology entitled: Fever and Neutropenia 10/92, Isfahan

11. Lecture at the Congress of Clinical Oncology of Tehran entitled: Chemotherapy in patients with renal failure, 93/7, Tehran

12. Lecture at Jihad Daneshgahi Breast Cancer Congress entitled: Drugs Used in Chemotherapy, 9/92, Tehran

13. Lecture at Jihad Daneshgahi Breast Cancer Congress entitled: Port and its care solutions, 8/93, Tehran


14. Lecture at the Congress of Urological Malignancies entitled: Treatment of Metastatic RCC, May 2015, Mashhad

15. Lecture at the Collective Congress of the University of Tehran entitled: Treatment of Re-Radiotherapy in Rectal Cancer, 3/94, Tehran

16. Lecture at the Cervical Cancer Congress, Azad University, entitled: Neo-Juvenile Therapy in Cervical Cancer, 5/94, Tehran

17. Lecture at the Immunology Conference of the Oncology Radiotherapy Association entitled: The Role of Immunoconcology in Gastric Cancer, 2/96,

Tehran

18. Lecture at the Immunoconferencing Conference of the Oncology Radiotherapy Association entitled: The Role of Immunoconcology in Cancer NSCLC, 12/96,

Tehran

19. Treatment induced cardiotoxicity 20. Lecture at Immunoconcology conference of ISRO entitled: Immunotherapy in

GI cancer , 17 may 2017, Tehran

21. Lecture at the Health Care Oncology Prostate Cancer Enlightening summit (HOPES 7) entitled: Trend Use of adjuvant & salvage radiotherapy after

Radical Prostatectomy and impact on long term survival results of 3 high volume

centers over last two 2 decades, 2017, Muscat

22. Lecture at 1st National congress on inflammation ,Immunology and inflammatory disorders entitled: importance of prevention & early detection in

cancer patients, 26 February 2019, Tehran

23. Lecture at 1st National congress on inflammation ,Immunology and inflammatory disorders entitled: different method of Immunoconcology , 26

February 2019, Tehran

24. Lecture at 3rd international Clinical Oncology Conference of the Iranian Radiotherapy Society, entitled: Trend Use of adjuvant & salvage radiotherapy

after Radical Prostatectomy and impact on long term survival , 2018 , Tehran

25.


II. panel member at scientific conferences

1. Member of the panel for dealing with non-melanoma skin tumors of the Iranian Society of Surgeons, / 10/88, Tehran

2. Member of the panel for dealing with the Rectal Cancer of Shahid Beheshti University of Medical Sciences, 5-4 / 12/89, Tehran

3. Panel member How to deal with bladder tumor of Iranian Urological Association, 7/7/90, Tehran

4. Member of the panel dealing with esophageal cancer, Shahid Beheshti University of Medical Sciences, 7/14/90, Tehran

5. Member of the bladder preservation panel in Iranian Cancer Society Congress , 7/29/90, Tehran

6. Member of the panel of palliative care in common gastrointestinal cancers of the Scientific Society of General Surgeons of Iran, 13/8/90, Tehran

7. Member of the Standardization Panel of Pathological Reports of the Iranian Scientific Society of Pathology, 7/7/92, Tehran

8. Member of Lung Cancer Treatment Panel, 91, Uremia

9. Member of the panel entitled: Colon Cancer , in 4th International Gastro Intestinal Cancer Congress , , 21 Feb 2019, Tehran

10. Member of the panel entitled: Metastatic liver disease, in 3rd International Gastro Intestinal Cancer Congress , 21 Feb 2019, Tehran , 24th November 2016 , Tehran

11. Member of the panel entitled: Rectal Cancer (watch & wait strategy) ,in 18th Hematology & Oncology congress ,14 Nov 1019, Tehran

12. Member of the panel entitled: Complicated Cases of Thyroid Carcinoma: Extended ,Metastatic ,Refractory, in 5th Head & Neck cancer congress,

31 July 2019, Tehran

13. Responsible member for site of radiotherapy in www.radiotherapy.sbmu.ac.ir


III. Panel Coordinator at scientific conferences

1. Coordinator of panel entitled: management of cancer patient with history of cardiovascular disorder ,in cardio oncology congress , 3 October 2017 ,

Tehran

2. Coordinator of panel entitled: Recurrence Management of well-diff Thyroid Carcinoma: When? Why? How?, in 5

th Head & Neck cancer

congress, 31 July 2019, Tehran

3. Coordinator of panel entitled: Early Stage Breast Cancer , in Grand Round of ISRO , 28 August 2019, Tehran

4. Coordinator of panel entitled: Advance Breast cancer HER2 +, in Grand Round of ISRO , 28 August 2019, Tehran

5. Coordinator of panel entitled: PTE & VTE, in Grand Round of ISRO , 10 July 2019, Tehran

6. Coordinator of panel entitled: Metastatic Colon Cancer, in Grand Round of ISRO , 2020, kish

AWARDS:

1. Awarded the top rank in the 4th Annual Congress of the Iranian Cancer Society for the article:

Meta-Analysts of Chemotherapy for Locally Advanced and Metastatic

Pancreatic Cancer: Secondary End Points

2. Awarded the top rank in the 5th Annual Congress of the Iranian Cancer Society for the article:

Comparison of 5FU-based chemoradiation with and without Eloxatin on

Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal

cancer

3. Awarded the highest rank in the 6th Annual Congress of the Iranian Cancer Society for the article:

A novel multiple marker bioassay utilizing HE4 and CA125 for the

prediction of ovarian cancer in patients with a pelvic mass


Holding Congresses And Scientific Seminars (courses and seminars celebration):

1. Member of the Scientific and Executive Committee of the Third Annual Conference of the Iranian Cancer Association, 8/16/86, Tehran

2. Member of the Scientific and Executive Committee of the Fourth Annual Conference of the Iranian Cancer Association, 3-1 / 8/87, Tehran

3. Member of the Scientific and Executive Committee of the 5th Annual Conference of the Iranian Cancer Society, 8/30/30/88, Tehran

4. Member of the Scientific and Executive Committee of the 6th Annual Conference of the Iranian Cancer Association, 8/30/99, Tehran

5. Member of the Scientific and Executive Committee of the 7th Annual Conference of the Iranian Cancer Association, 8/10/30/89, Tehran

6. Member of the Scientific and Executive Committee of the First NET Conference of the Iranian Cancer Association / 4/88, Tehran

7. Member of the Scientific and Executive Committee of the Second NET Conference of the Iranian Cancer Association, 8/4/89, Tehran

8. Member of the Scientific and Executive Committee of the RCC Conference of the Iranian Cancer Association, 6/29/89, Tehran

9. Member of the Scientific and Executive Committee of the GIST Conference of the Iranian Cancer Association, 7/22/89, Tehran

10. Member of the Scientific and Executive Committee of the Annual Clinical Oncology Conference of the Iranian Radiotherapy Society, 10-29/30/89,

Tehran

11. Member of the Scientific and Executive Committee of the 3rd International Congress on Supportive and Palliative Care in Cancer, 8-15

/ 10/17/89, Tehran

12. Member of the Scientific and Executive Committee of the Conference on Thromboembolism and Cancer of the Iranian Cancer Association,

10/28/89, Tehran

13. Member of the Scientific and Executive Committee of the Cancer Emergency Conference of the Iranian Cancer Association, 3/5/90, Tehran

14. Scientific Secretary of Cancer Conference with Unknown Origin of Iranian Cancer Association, 6/5/90, Tehran


15. Scientific Secretary of the Nursing Program of the 7th Annual Conference of the Iranian Cancer Association, 7/29/90/90, Tehran

16. Scientific Secretary of the 13th Annual Conference on Iranian Pathology, 7/29/90/90, Tehran

17. Member of the Scientific and Executive Committee of the Annual Clinical Oncology Conference of the Iranian Radiotherapy Society, 91, Tehran

18. Member of the Scientific and Executive Committee of the Annual Clinical Oncology Conference of the Iranian Radiotherapy Society, 92,

Tehran

19. Member of the Scientific and Executive Committee of the Annual Clinical Oncology Conference of the Iranian Radiotherapy Society, 93, Tehran

20. Scientific Secretary of the Conference on Thromboembolism and Cancer of the Iranian Radiotherapy Society, 5/23/93, Tehran

21. Member of the Scientific Committee of Jihad University Breast Cancer Congress, 92, Tehran

22. Member of the Scientific Committee of Jihad University Breast Cancer Congress, 93, Tehran

23. Scientific Secretary of Immunoconference Conference, 3/12/96, Tehran

24. Member of the Scientific and Executive Committee of WACC 2016 , Iranian Cancer Association , November 2016,Tehran

25. Member of the Scientific and Executive Committee of WACC 2017 , Iranian Cancer Association , November 2017,Tehran

26. Member of the Scientific and Executive Committee of WACC 2019 , Iranian Cancer Association , February 2019,Tehran

27. Member of the Scientific Committee of 1st National congress on inflammation ,Immunology and inflammatory disorders, February 2019,

Tehran

28. Member of the Scientific and Executive Committee of the 3rd international Clinical Oncology Conference of the Iranian Radiotherapy

Society, 2018, Tehran


Workshop (EDC):

1. Certificate Of Attendance In Basic Good Clinical Practice Training Program, 26th - 27th, 2013, Akademika International Institute .Turkey

2. Attending the 3-day training workshop on curriculum planning from 25 to 27 January 2012 in the Faculty of Rehabilitation Sciences, Shahid Beheshti

University of Medical Sciences

3. Attending a 4-day training workshop on teaching methods from 2-3-9-10 January 2012, which was held by the Center for Studies and Development of

Shahid Beheshti University of Medical Sciences

4. Attending a 1-day workshop on organizational ethics and patient satisfaction management was held on May 6, at Shahid Beheshti University of Medical

Sciences

5. Attending a 2-day workshop on professional ethics was held at Shahid Beheshti University of Medical Sciences

6. Attending a 1-day workshop on Hemovigilance was held on 2 April 2016 at Tehran

7. Attending a 1-day workshop on Brain Death was held on 9 April 2015 at Imam Hosein Hospital ,Tehran

8. Attending a 3-day workshop on Tariff writing (radiotherapy codes for coding Iran's oncology radiotherapy services) was held from 10-12 October 2013 at

Tehran

9. Attending a 1-day workshop on OVID information data was held at Imam Hosein Hospital ,Tehran

10. Attending a 1-day workshop on EBM was held in 25 September 2016 at Tehran

11. Certificate Of Attendance In needment to be recognized as NETWORK, January 5th, 2011, Nooran Telecommunication, Tehran-Iran

12. Passing the course of introductory student evaluation methods in the second semester of the academic year 91-92 in the master's degree program of medical

education, Faculty of Medical Sciences, Shahid Beheshti University of Medical

Sciences

13. Passing the course of teaching methods in the second semester of the 91-92 academic year in the master's degree program of medical education, Faculty of

Medical Education, Shahid Beheshti University of Medical Sciences


14. Passing the basic communication skills course in the second semester of the 91-92 academic year in the master's degree program of medical education, Faculty of

Medical Sciences, Shahid Beheshti University of Medical Sciences

15. Passing the evaluation course of the introductory program in the second semester of the 91-92 academic year in the master's degree program of medical


Sciences

16. Passing the introductory course planning course in the second semester of the 91-92 academic year in the master's degree program of medical education,

Faculty of Medical Sciences, Shahid Beheshti University of Medical Sciences

17. Passing the course of computer application in education 1 in the second semester of the academic year of 1991-92 in the master's degree program of medical


Sciences

18. Passing the advanced course planning course in the first semester of the 92-93 academic year in the master's degree program of medical education, Faculty of

Medical Education, Shahid Beheshti University of Medical Sciences

19. Passing the course of learning and teaching patterns in the first semester of the 92-93 academic year in the master's degree program of medical education,


20. Passing the course of computer application in education 2 in the first semester of the 92-93 academic year in the master's degree program of medical education,


21. Passing the course of quantitative methods of research in education in the first semester of the 92-93 academic year in the master's degree program of medical


Sciences

22. Passing the course of qualitative methods of research in education in the first semester of the 92-93 academic year in the master's degree program of medical


Sciences

Research Project

1. Collaborator in the National Research Project to investigate the prevalence and causes of occupational depression (Burnout) in caregivers of cancer patients of

the Iranian Cancer Society


2. Collaborator in a Research Project to study the causes and problems of patients with cancer and its relationship with socio-economic factors in Iran Cancer

Society of Iran

3. Collaborator in a Research Project on the relationship between mRNA genes of TS & ERCC1 genes with clinical pathological features and tumor location in

gastrointestinal cancers of the Iranian Cancer Society

4. Collaborator in Tinagrast clinical trial Research Project (Ariatinagen) compared to Neupogen (Amgen) for the prevention of fever and neutropenia caused by

chemotherapy in Cancer Patients

5. Collaborator in a Research Project to study the clinical and pathological features and common treatments of gastric and breast cancer in Iran, Iranian Cancer

Society

6. Collaborator in a Research Project to investigate the response to treatment and the ability of resuscitation with chemotherapy in comparison with preoperative

chemoradiation with a diet containing two taxol in cancer patients of the Iranian

Cancer Society

7. Executor of Research Project of Pharmacokinetics Assessment Of Paclinab® Formulation And Compared to Abraxane® Formulation In Patients With Solid

Tumors

8. Executor of Research Project PDLASTA Formulation study Post-marketing

9. Executor of Research Project of The value of DW-MRI in predicting pathologic complete response (pCR) after neoadjuvant chemoradiation in patient with

rectal cancer who referred to Imam Hossein hospital during July 2018 to July

2019

10. Executor of Research Project of Evaluation of treatment outcomes of induction chemotherapy and then Neoadjuvant chemoradiotherapy and surgery in locally

advanced rectal cancer

11. Collaborator in a Research Project of the predictive value of cardiac biochemical markers including high sensitive cardiac troponin-I (HSCT-I), NT-Pro-BNP and

two dimensional echocardiography in early detection of acute and sub acute

cardiac toxicity in patients who are treated by anthracycline drug.

12. Collaborator in a Research Project of A comparison survey on the combination Aprepitant - dexamethasone - Ondansetron, vs. Placebo-dexamethasone -

Ondansetron, for prevention of Moderate Emetogenic Chemotherapy Regimens-

Induced Nausea and Vomiting

13. Collaborator in a Research Project of Evaluation of Estrogen, Progesterone & HER2 receptor in Iranian population of Breast Cancer


Guideline

1. Breast Cancer Guideline , Member of the Oncology Guideline Committee in Ministry of Health

2. Colon Cancer Guideline , Member of the Oncology Guideline Committee in Ministry of Health

3. Bevacizumab Drug Guideline , Member of the Oncology Guideline Committee in Ministry of Health

4. Imatinib Drug Guideline , Member of the Oncology Guideline Committee in Ministry of Health

5. Pemetrexed Drug Guideline , Member of the Oncology Guideline Committee in Ministry of Health

6. Sorafenib Drug Guideline , Member of the Oncology Guideline Committee in Ministry of Health

7. Liposomal Doxorubicin Drug Guideline , Member of the Oncology Guideline Committee in Ministry of Health

8. Temozolomide Drug Guideline , Member of the Oncology Guideline Committee in Ministry of Health

9. Bortezomib Drug Guideline , Member of the Oncology Guideline Committee in Ministry of Health

10. Rituximab Drug Guideline , Member of the Oncology Guideline Committee in Ministry of Health

11. Management of Oncologic patients in Corona Pandemic , Member of the Oncology Guideline Committee in Ministry of Health

12. Prostate Cancer Guideline , Member of the Guideline Committee of Uro oncology in SBMU Urology research center

13. Testicular Cancer Guideline , Member of the Guideline Committee of Uro oncology in SBMU Urology research center

14. Kidney Cancer Guideline , Member of the Guideline Committee of Uro oncology in SBMU Urology research center

15. Bladder Cancer Guideline , Member of the Guideline Committee of Uro oncology in SBMU Urology research center


Media

1. Due to the importance of the mass media in the prevention and early detection of cancer, about 100 live TV programs have been recorded and

broadcast on the health network under the title of heart rate.

2. Meanwhile, about 200 trailers were recorded for a few minutes as intermediate programs, which were repeatedly broadcast on the health

network.

3. social network is very important in new world, so live interview with fuscous on oncologic topic plan, weekly in Instagram app

ACTIVITIES IN ONCOLOGY FIELD:

1. Visit and follow up on 6000 cancer patients, of which about 350 newly

diagnosed patients are visited and treated.

2. Treatment of cancer patients with various radiotherapy and oncology devices,

including brachytherapy, 6 & 18 MV accelerator

3. Treatment of cancer patients with various chemotherapy , hormone therapy &

immunotherapy protocols

4. Active participation in the training of radiotherapy and oncology assistants in

the form of journal club, review of reference books, in the clinic and on patients'

beds, grand round and holding written exams and OSCE

5. Active participation in the Grand Round of the Oncology Hematology

Department of Taleghani Hospital affiliated to Shahid Beheshti University of

Medical Sciences

Favorites

o Gastrointestinal cancer o Breast cancer o Molecular biology of cancer o IMRT o Radioisotopes o Journalism in oncology

Documents

Curriculum Vitae Ali Yaghobi Joybari · 2020. 6. 16. · 4. Behzadi, Behnaz, Evaluation of treatment outcomes of induction chemotherapy and then Neoadjuvant chemoradiotherapy and